In this Bottom Line Blog post, Dr. Diane Palmieri, director of NCI’s Center for Research Strategy, spotlights major goals from the NCI Fiscal Year 2026 Annual Plan and Professional Judgment Budget Proposal. She emphasizes NCI’s strong support for early-stage investigators and the importance of engaging every person to end cancer as we know it for all people. https://go.nih.gov/bw1SOv1 #NCIFuture
National Cancer Institute (NCI)
Government Administration
Bethesda, MD 308,548 followers
The National Cancer Institute, part of the National Institutes of Health, is the lead federal agency for cancer research
About us
The National Cancer Institute (NCI), part of the National Institutes of Health, is the lead federal agency for cancer research. For more information about NCI, visit us at www.cancer.gov. Privacy policy: https://www.cancer.gov/policies/privacy-security Engagement ≠ endorsement
- Website
-
http://www.cancer.gov
External link for National Cancer Institute (NCI)
- Industry
- Government Administration
- Company size
- 1,001-5,000 employees
- Headquarters
- Bethesda, MD
- Type
- Government Agency
- Specialties
- cancer, cancer research, cancer training, cancer research grants, cancer resources, cancer information, and cancer research funding
Locations
-
Primary
9500 Rockville Pike
Bethesda, MD 20892, US
-
9609 Medical Center Drive
Rockville, MD 20850, US
-
Ft. Detrick U.S. Army Facility
Frederick, MD, US
Employees at National Cancer Institute (NCI)
Updates
-
National Cancer Institute (NCI) reposted this
🎉 Last week, we celebrated the incredible career of Steven A. Rosenberg, M.D., Ph.D., Chief of the Surgery Branch. Hundreds of attendees both in-person and online came together to honor his pioneering in the development of effective immunotherapies for patients with advanced cancer. Former and current colleagues, trainees and patients were able to thank Dr. Rosenberg for his impact on the field and discuss the optimism they have for the future of cancer research because of his work. Thank you to the Center for Excellence in Immunology for sponsoring, the organizers and to everyone who participated in this incredible symposium. 👏 Share your favorite photo if you attended or a memory you have with Dr. Rosenberg in the comments! National Cancer Institute (NCI), NIH Clinical Center (CC), The National Institutes of Health
-
JOB OPENING: NCI seeks an innovative leader to serve as the Associate Director of the Surveillance Research Program for the Division of Cancer Control and Population Sciences (DCCPS). The mission of DCCPS is to provide national and international leadership in supporting research in surveillance, epidemiology, health services, behavioral science, and cancer survivorship. Submit your application today: https://lnkd.in/eju-jsVu
-
Did you know that NCI Cancer Epidemiology and Genetics is involved in many studies in Latin America? Read about research that promises to advance our understanding of cancer risk among Latino individuals in the U.S. and to inform prevention efforts at home and abroad. https://go.nih.gov/cOZY9EG
-
How has NCI's investor initiative help funded start-ups? Have any been acquired? Check out our podcast episode on our Small Business Innovation Research Innovation Lab to find out the investor initiative's unique opportunities. https://go.nih.gov/rrb13XO Train at NCI
-
A recent study in mice suggested that manipulating an immune cell may make radiation therapy more effective. Learn more about this research: https://go.nih.gov/TjcPcyu Image Description: After gene therapy is used to boost levels of the BAMBI protein in certain immune cells in the tumor microenvironment, an improved tumor response is seen in radiation therapy. Credit: Adapted from Journal of Clinical Investigation. https://lnkd.in/e_eWJJAW. CC BY 4.0.
-
Regular imaging tests to monitor the pancreas may help detect pancreatic cancer at an early stage in people who are at high risk, a new study suggests. This type of surveillance could also help improve how long these patients live. Read more. https://go.nih.gov/8iL9XXn
-
We are thinking of everyone affected by Hurricane Helene and stand with you during this difficult time. Please stay safe, follow local advisories, and visit our emergency resources page to view information for those with cancer, NCI grantees, and NCI staff. https://go.nih.gov/Ke9r5VG
-
WATCH: NCI's Cancer Information Service can help to answer your cancer-related questions whether you are a patient, family or friend, health care provider, or researcher. Call, email, or live chat with an information service provider today. https://go.nih.gov/wsVl7An
-
The FDA has approved a cellular therapy called afamitresgene autoleucel, or afami-cel (Tecelra), to treat some people with metastatic synovial sarcoma, a type of soft tissue sarcoma. The decision marks the first time the agency has approved a treatment called a T-cell receptor therapy for cancer. https://go.nih.gov/lzZGeh6 Media Description: T-cell receptor therapy uses an enhanced form of a T-cell receptor, or TCR, to bind to HLA-presenting antigens (protein fragments) on cancer cells. After binding, the T cells can then kill the cancer cells.